Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-23-009093
Filing Date
2023-10-27
Accepted
2023-10-27 16:41:06
Documents
24

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1896354
2 filename2.htm EX-3.1 143022
3 filename3.htm EX-3.2 127163
4 filename4.htm EX-4.2 269236
5 filename5.htm EX-10.1 204451
6 filename6.htm EX-10.2 307757
7 filename7.htm EX-10.6 128655
8 filename8.htm EX-10.7 502470
9 filename9.htm EX-10.8 22654
10 filename10.htm EX-10.9 104109
11 filename11.htm EX-10.10 122320
12 filename12.htm EX-10.11 115997
13 GRAPHIC g551455g03p01.jpg GRAPHIC 56517
14 GRAPHIC g551455g08o97.jpg GRAPHIC 143139
15 GRAPHIC g551455g12m13.jpg GRAPHIC 147847
16 GRAPHIC g551455g13p01.jpg GRAPHIC 119133
17 GRAPHIC g551455g15m15.jpg GRAPHIC 271158
18 GRAPHIC g551455g19a20.jpg GRAPHIC 165687
19 GRAPHIC g551455g22a22.jpg GRAPHIC 34977
20 GRAPHIC g551455g23a23.jpg GRAPHIC 111898
21 GRAPHIC g551455g24a25.jpg GRAPHIC 127209
22 GRAPHIC g551455g59q43.jpg GRAPHIC 180424
23 GRAPHIC g551455g78c79.jpg GRAPHIC 64429
24 GRAPHIC g551455g89m10.jpg GRAPHIC 105070
  Complete submission text file 0000950123-23-009093.txt   6051117
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06934 | Film No.: 231356058
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)